Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports
Abstract Data addressing safety concerns related to potential drug interactions between cannabis‐derived products and pharmaceutical medications in the pediatric population…
Abstract Data addressing safety concerns related to potential drug interactions between cannabis‐derived products and pharmaceutical medications in the pediatric population…
Abstract Background: Chronic non-cancer pain may affect up to 51% of the general population. Pharmacist interventions have shown promise in…
Abstract Background: Legal cannabis is available in more than half of the United States. Health care professionals (HCPs) rarely give…